Marks the fourth investment completed under Angelini Ventures’ €150 million co-investment partnership with the European Investment Bank in less ...

Erasca is now a fully funded fast follower in RAS-targeted oncology, with ~$1B pro forma liquidity and three potential ...

A new review details how the Runx1 and Gata2 transcription factors architect the epigenetic landscape of blood formation and ...

A new review describes how NMDA glutamate receptors on myeloid cells drive calcium-dependent reprogramming toward ...

Zenas BioPharma (ZBIO) advances obexelimab for IgG4-RD with a May 2027 PDUFA, strong cash runway and key catalysts ahead—read ...

Agentic AI threatens to disrupt India e-commerce and advertising models as software replaces human browsing, shifting control ...

Slate Asset Management (“Slate”), a global investor and manager focused on essential real estate and infrastructure assets, and One Investment Management (“OneIM”), a global alternative investment ...

Global, first-in-human study underway designed to evaluate safety, tolerability, and initial clinical efficacy of PM577a -- ...

Spanish Foundations is the newest addition to KinderCare’s Learning Adventures program: small group enrichment classes offered in KinderCare Learning Centers for children ages 2-12. Other Learning ...

Indonesia’s air force chief has said “Just wait” when questioned about possible Chengdu J-10 arrivals, leaving delivery details unresolved while highlighting the airpower and logistics implications of ...

RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it has been awarded a Research & Development grant from Scottish Enterprise to ...

Forward Therapeutics, Inc. (“Forward” or the “Company”), a clinical-stage biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today announced positive ...